We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
COVID-19 physical distancing requirements forced change in how traditional clinical trials were conducted and a new Informa Pharma and Oracle study shows the industry is not looking back.